iSpecimen Inc. (ISPC) stock

ISPCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 7/3028% below fair value

$0.71−0.03 (-3.81%)

Close on Nov 11, 2026Market cap $1.79MP/E –Yield –

iSpecimen cash

Cash and short-term investments held at the end of each period.

iSpecimen's cash was $4.41M at Jun 30, 2026. For fiscal 2025 it was $6.88M, up 266.3% from the year before. The highest annual figure on record is $27.74M in fiscal 2021.

Annual cash

Period	Period end	Value	Change
FY2025	Dec 31, 2025	$6.88M	+266.3%
FY2024	Dec 31, 2024	$1.88M	-62.5%
FY2023	Dec 31, 2023	$5.01M	-67.3%
FY2022	Dec 31, 2022	$15.31M	-44.8%
FY2021	Dec 31, 2021	$27.74M	+3886.0%
FY2020	Dec 31, 2020	$695.91K	+1191.3%
FY2019	Dec 31, 2019	$53.89K	–

Quarterly cash

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q2 FY2026	Jun 30, 2026	$4.41M	+649.8%
Q1 FY2026	Mar 31, 2026	$2.82M	+260.2%
Q4 FY2025	Dec 31, 2025	$6.88M	+266.3%
Q3 FY2025	Sep 30, 2025	$2.78M	+58.8%
Q2 FY2025	Jun 30, 2025	$588.78K	-72.6%
Q1 FY2025	Mar 31, 2025	$782.56K	-69.4%
Q4 FY2024	Dec 31, 2024	$1.88M	-62.5%
Q3 FY2024	Sep 30, 2024	$1.75M	-69.1%
Q2 FY2024	Jun 30, 2024	$2.15M	-73.8%
Q1 FY2024	Mar 31, 2024	$2.56M	-76.8%
Q4 FY2023	Dec 31, 2023	$5.01M	-67.3%
Q3 FY2023	Sep 30, 2023	$5.66M	-72.6%
Q2 FY2023	Jun 30, 2023	$8.21M	-65.3%
Q1 FY2023	Mar 31, 2023	$11.02M	-57.8%
Q4 FY2022	Dec 31, 2022	$15.31M	-44.8%
Q3 FY2022	Sep 30, 2022	$20.66M	+111.0%
Q2 FY2022	Jun 30, 2022	$23.69M	+79.7%
Q1 FY2022	Mar 31, 2022	$26.10M	+7249.3%
Q4 FY2021	Dec 31, 2021	$27.74M	+3886.0%
Q3 FY2021	Sep 30, 2021	$9.79M	+922.8%
Q2 FY2021	Jun 30, 2021	$13.18M	+913.7%
Q1 FY2021	Mar 31, 2021	$355.13K	+558.9%
Q4 FY2020	Dec 31, 2020	$695.91K	–
Q3 FY2020	Sep 30, 2020	$957.25K	–
Q2 FY2020	Jun 30, 2020	$1.30M	–
Q4 FY2019	Dec 31, 2019	$53.89K	–